Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.Financial_Report.xls
10-K - FORM 10-K - Oncologix Tech Inc.oncologix8312012.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R18.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R20.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R19.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R12.htm
EX-21 - SUBSIDIARIES OF ONCOLOGIX TECH, INC. - Oncologix Tech Inc.oncologix8312012exh21.htm
EX-99 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Oncologix Tech Inc.oncologix8312012exh99.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - Oncologix Tech Inc.oncologix8312012exh312.htm
EX-32.1 - CERTIFICATION - Oncologix Tech Inc.oncologix8312012exh321.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - Oncologix Tech Inc.oncologix8312012exh311.htm
EX-32.2 - CERTIFICATION - Oncologix Tech Inc.oncologix8312012exh322.htm
v2.4.0.6
Consolidated Statements of Operations (USD $)
12 Months Ended 15 Months Ended
Aug. 31, 2012
Aug. 31, 2011
Aug. 31, 2012
Operating expenses:      
General and administrative $ 130,769 $ 195,067 $ 164,795
Depreciation and amortization 450 1,471 966
Total operating expenses 131,219 196,538 165,761
Loss from operations (131,219) (196,538) (165,761)
Other income (expense):      
Interest and finance charges (10,768) (14,707) (13,768)
Interest and finance charges - related parties (25,312) (18,241) (30,123)
Loss on conversion of notes payable - related parties (92,758)    (92,758)
Induced conversion expense (25,402) (6,076) (31,479)
Loss on disposal of assets (110)    (110)
Other expenses    (47)   
Total other income (expense) (154,350) (39,071) (168,238)
Loss from operations (285,569) (235,609) (333,999)
Less loss attributable to noncontrolling interest (14) (13) (17)
Net loss before income taxes (285,555) (235,596) (333,982)
Income taxes         
Net loss attributable to common shareholders $ (285,555) $ (235,596) $ (333,982)
Loss per common share, basic and diluted: $ (0.01) $ 0.00  
Weighted average number of shares outstanding - basic and diluted 54,443,649 47,915,734